Skip to main content
. 2022 Sep 27;13:892453. doi: 10.3389/fpsyt.2022.892453

Table 2.

Basic information included in the study.

Study Country Age (X ±S) Sample (M) Patient (disease)
Siu et al. (16) China 67.3 320 (64) Chronic insomnia
Cheung et al. (22) China 60.06 30 (16) Lung cancer
Yilmaz Gokmen et al. (26) Turkey 48.06 50 (31) Obstructive sleep apnea
Jones et al. (30) America 54 101 (7) Fibromyalgia patients
Nguyen et al. (32) Germany 68.9 96 (48) Older people
Wang et al. (21) America 50.1 66 (9) Fibromyalgia patients
Irwin et al. (33) America 65.55 123 (35) Chronic and primary insomnia
Taylor-Piliae et al. (35) America 69.3 28 (17) Post-stroke with sleep complaints
Taylor-Piliae et al. (36) America 69.9 145 (77) Post-stroke with sleep complaints
Wang et al. (24) America 51.8 226 (17) Fibromyalgia
Lü et al. (29) China 64.57 46 (0) Knee osteoarthritis (OA)
Maddali Bongi et al. (37) Italy 52.24 44/(N) Fibromyalgia syndrome
Irwin et al. (15) America 69.9 112 (41) Healthy older adults
Zhu et al. (23) China 35.65 80 (0) Dependent on amphetamine-type stimulant
McQuade et al. (28) America 64.47 66 (66) Prostate cancer
Larkey et al. (31) America 58.8 101 (0) Breast cancer survivors
Frye et al. (20) America 69.2 84 (30) Older people
Li et al. (25) America 75.37 118 (22) Older adults with sleep complaints
Irwin et al. (34) America 59.8 90 (0) Breast cancer survivors
Wang et al. (38) Japan 77 34 (12) The elderly with cerebral vascular disorder
Hosseini et al. (27) Iran. 69.1 62 (30) Insomnia